Substances · Lysergamides
AL-LAD
- Preferred name
- AL-LAD
- IUPAC name
- (6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Parent CAS number (reference)
- 65527-61-9
- Molecular formula
- C22H27N3O
- Molecular weight
- 349.5 g/mol
- InChIKey
- JCQLEPDZFXGHHQ-OXQOHEQNSA-N
- PubChem
- CID 15227511
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
6-allyl-6-nor-LSD N-Allylnor-LSD ALLAD AL LAD
Verified Neurochemical & Toxicological Intelligence
AL-LAD
Receptor Telemetry & Mechanism of Action
Direct active N6-allyl-nor-LSD analogue (not a prodrug to LSD-25) with potent 5-HT2A/5-HT1A receptor agonism and modified N6 steric binding.
Biotransformation & Active Metabolites
Directly active at 5-HT2A without hydrolyzing to LSD-25.
Temporal Pharmacokinetics
N6-Allyl Lysergamide (5-HT2A Partial Agonist) — Supplied as dissolved liquid solution; differs from 1P-LSD/1cP-LSD by being shorter (6–9 h vs 8–12 h) with brighter visual geometry and lighter cognitive introspection at low-to-common amounts, though steep above 200 ug.
- Onset 30–75 min
- Peak Window 1.5–3.5 h
- Total Window 6–9 h
- Residual / Half-Life 3–5 h after-effects
Supplied as dissolved liquid solution; differs from 1P-LSD/1cP-LSD by being shorter (6–9 h vs 8–12 h) with brighter visual geometry and lighter cognitive introspection at low-to-common amounts, though steep above 200 ug.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
20–40 ug
Subtle threshold receptor activity (N6-Allyl Lysergamide (5-HT2A Partial Agonist)).
Minimal baseline autonomic shift.
40–80 ug
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
80–160 ug
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
160–250 ug
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
250+ ug
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.
Lowers seizure threshold alongside 5-HT2A excitation.
Elevated Hazard — Avoid
Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.
Caution / Receptor Attenuation
Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.
Structural Isomer & Sibling Comparison
Supplied as dissolved liquid solution; differs from 1P-LSD/1cP-LSD by being shorter (6–9 h vs 8–12 h) with brighter visual geometry and lighter cognitive introspection at low-to-common amounts, though steep above 200 ug.
Physicochemical Stability & Storage
Physical Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.
Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.
Cross-Tolerance & Dependence Profile
Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.
Codes on this card
Short meanings for the abbreviations printed with this substance.
5-HT₂ₐ
Serotonin receptor 5-HT2A
5-HT is the laboratory name for serotonin. 2A is one subtype of its receptor. Lysergamide, tryptamine, and many 2C-family cards cite this receptor.
Kᵢ
Binding tightness in nanomoles
Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.
curve
Concentration-response curve
The response curve plots concentration along the bottom and the measured laboratory response up the side. It is usually flat, then steep, then flat again near the top. EC50 sits on the steep middle.
T½
Half-life
Half-life is the time it takes a measured concentration to fall by half. After one half-life, half remains. After another, a quarter of the original measurement remains.
CAS
CAS registry number
A CAS number is a passport number for one chemical entry in the CAS registry. The free base and a salt of the same parent usually have different CAS numbers.
1 mg / µg
Calibrated Physical Form (1 mg Tablets, µg Liquid, Crystal)
Milligram-scale benzodiazepines are supplied as 1 mg tablets (1 tablet = 1 mg), microgram lysergamides as dissolved liquid (µg), and standard compounds as pure crystal or powder.
MAOI / IMAO
Monoamine Oxidase Inhibitors (MAOIs)
Compounds and medications that block the enzyme responsible for breaking down serotonin, dopamine, and norepinephrine; combining them with monoamine releasers is life-threatening.
5-HT ↑↑
Serotonergic Overload (Serotonin Toxicity)
A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.
Chemical Architecture & Structural Profile
AL-LAD ((6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide) is a reference compound belonging to the Lysergamides class, characterized by the molecular formula C22H27N3O and a molar mass of 349.5 g/mol. The parent molecule is indexed under CAS registry number 65527-61-9 and in the NCBI PubChem database as CID 15227511 (Standard InChIKey: JCQLEPDZFXGHHQ-OXQOHEQNSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), AL-LAD is indexed within the Lysergamides structural group. Toxicological notes (PsychonautWiki): toxic dose is unknown, extremely low toxicity. Dependence liability (PsychonautWiki): not habit-forming. Documented cross-tolerance class: psychedelic. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Riksdagen — Förordning (1999:58) om förbud mot vissa hälsofarliga varor — Sveriges riksdag (2026-11-12)